Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification

INTRODUCTION: Candidacy for anti-HER2 adjuvant therapy in breast cancer is assessed using tumour HER2 status but recently it has been proposed that the transcription factors AP-2α and YY1 may cause Her2 protein overexpression independently of gene amplification. METHODS: We characterised AP-2α/β, AP...

Descripción completa

Detalles Bibliográficos
Autores principales: Powe, Desmond G, Akhtar, Gulfareen, Habashy, Hany Onsy, Abdel-Fatah, Tarek, Rakha, Emad A, Green, Andrew R, Ellis, Ian O
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815554/
https://www.ncbi.nlm.nih.gov/pubmed/20025767
http://dx.doi.org/10.1186/bcr2461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815554/
https://www.ncbi.nlm.nih.gov/pubmed/20025767
http://dx.doi.org/10.1186/bcr2461

Ejemplares similares